17-81511890-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000574671.6(ACTG1):​n.500C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.453 in 1,613,646 control chromosomes in the GnomAD database, including 171,136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 15748 hom., cov: 33)
Exomes 𝑓: 0.45 ( 155388 hom. )

Consequence

ACTG1
ENST00000574671.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.936

Publications

26 publications found
Variant links:
Genes affected
ACTG1 (HGNC:144): (actin gamma 1) Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
ACTG1 Gene-Disease associations (from GenCC):
  • Baraitser-winter syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss 20
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Baraitser-Winter cerebrofrontofacial syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-81511890-G-T is Benign according to our data. Variant chr17-81511890-G-T is described in ClinVar as Benign. ClinVar VariationId is 44147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.831 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000574671.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTG1
NM_001614.5
MANE Select
c.363+13C>A
intron
N/ANP_001605.1
ACTG1
NM_001199954.3
c.363+13C>A
intron
N/ANP_001186883.1
ACTG1
NR_037688.3
n.435+13C>A
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTG1
ENST00000574671.6
TSL:1
n.500C>A
non_coding_transcript_exon
Exon 3 of 5
ACTG1
ENST00000573283.7
TSL:5 MANE Select
c.363+13C>A
intron
N/AENSP00000458435.1
ACTG1
ENST00000575842.5
TSL:1
c.363+13C>A
intron
N/AENSP00000458162.1

Frequencies

GnomAD3 genomes
AF:
0.448
AC:
68121
AN:
151982
Hom.:
15728
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.399
Gnomad AMI
AF:
0.658
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.470
Gnomad EAS
AF:
0.852
Gnomad SAS
AF:
0.626
Gnomad FIN
AF:
0.419
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.429
Gnomad OTH
AF:
0.455
GnomAD2 exomes
AF:
0.498
AC:
124455
AN:
250080
AF XY:
0.501
show subpopulations
Gnomad AFR exome
AF:
0.396
Gnomad AMR exome
AF:
0.505
Gnomad ASJ exome
AF:
0.469
Gnomad EAS exome
AF:
0.875
Gnomad FIN exome
AF:
0.420
Gnomad NFE exome
AF:
0.435
Gnomad OTH exome
AF:
0.465
GnomAD4 exome
AF:
0.453
AC:
662233
AN:
1461546
Hom.:
155388
Cov.:
74
AF XY:
0.459
AC XY:
333405
AN XY:
727076
show subpopulations
African (AFR)
AF:
0.400
AC:
13374
AN:
33470
American (AMR)
AF:
0.504
AC:
22520
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.468
AC:
12227
AN:
26132
East Asian (EAS)
AF:
0.820
AC:
32559
AN:
39696
South Asian (SAS)
AF:
0.611
AC:
52715
AN:
86254
European-Finnish (FIN)
AF:
0.423
AC:
22552
AN:
53328
Middle Eastern (MID)
AF:
0.520
AC:
2992
AN:
5750
European-Non Finnish (NFE)
AF:
0.427
AC:
475157
AN:
1111830
Other (OTH)
AF:
0.466
AC:
28137
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
22427
44854
67282
89709
112136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14684
29368
44052
58736
73420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.448
AC:
68176
AN:
152100
Hom.:
15748
Cov.:
33
AF XY:
0.454
AC XY:
33724
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.399
AC:
16558
AN:
41478
American (AMR)
AF:
0.471
AC:
7199
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.470
AC:
1630
AN:
3470
East Asian (EAS)
AF:
0.852
AC:
4401
AN:
5164
South Asian (SAS)
AF:
0.629
AC:
3031
AN:
4822
European-Finnish (FIN)
AF:
0.419
AC:
4440
AN:
10590
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.429
AC:
29197
AN:
67984
Other (OTH)
AF:
0.462
AC:
974
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1963
3926
5890
7853
9816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.440
Hom.:
32572
Bravo
AF:
0.452
Asia WGS
AF:
0.695
AC:
2417
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 15, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

363+13C>A in Intron 03 of ACTG1: This variant is not expected to have clinical s ignificance because it is not located within the conserved splice consensus sequ ence and has been identified in 43.2% (3019/6996) of European American chromosom es from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs. washington.edu/EVS; dbSNP rs9910792).

Mar 07, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Autosomal dominant nonsyndromic hearing loss 20 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autosomal dominant nonsyndromic hearing loss 20;C3281235:Baraitser-winter syndrome 2 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Baraitser-winter syndrome 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.013
DANN
Benign
0.64
PhyloP100
-0.94
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9910792; hg19: chr17-79478916; COSMIC: COSV59509699; COSMIC: COSV59509699; API